136
Views
0
CrossRef citations to date
0
Altmetric
Review

Non-invasive Radiofrequency Ablation of Malignancies Mediated By Quantum dots, Gold Nanoparticles and Carbon Nanotubes

&
Pages 1325-1330 | Published online: 13 Oct 2011

Bibliography

  • Curley SA . Radiofrequency ablation leads to excellent local tumor control and durable longterm survival in specific subsets of early stage HCC patients confirming to the Milan criteria. Ann. Surg.252(6), 913–914 (2010).
  • Yu J , LiangP, YuX, LiuF, ChenL, WangY. A comparison of microwave ablation and bipolar radiofrequency ablation both with an internally cooled probe: Results in ex vivo and in vivo porcine livers. Eur. J.Radiol.79(1), 124–130 (2011).
  • Curley SA . Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? Ann. Surg. Oncol15(1), 11–13 (2008).
  • Fernando HC , De Hoyos A, Landreneau RJ et al. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates. J. Thorac. Cardiovasc. Surg129(3), 639–644 (2005).
  • Abdellaoui A , WatkinsonAF. Radiofrequency ablation of renal tumors. Future Oncol.4(1), 103–111 (2008).
  • Roschmann P . Radiofrequency penetration and absorption in the human body: limitations to high-field whole-body nuclear magnetic resonance imaging. Med. Phys14(6), 922–931 (1987).
  • Cheung AY , NeyzariA. Deep local hyperthermia for cancer therapy: external electromagnetic and ultrasound techniques. Cancer Res.44(Suppl. 10), 4736s–4744s (1984).
  • Letfullin RR , IversenCB, GeorgeTF. Modeling nanophotothermal therapy: kinetics of thermal ablation of healthy and cancerous cell organelles and gold nanoparticles. Nanomedicine7(2), 137–145 (2011).
  • Cherukuri P , GlazerES, CurleySA. Targeted hyperthermia using metal nanoparticles. Adv. Drug Deliv. Rev62(3), 339–345 (2010).
  • Glazer ES , ZhuC, MasseyKLet al. Noninvasive radiofrequency field destruction of pancreatic adenocarcinoma xenografts treated with targeted gold nanoparticles. Clin. Cancer Res 16(23), 5712–5721 (2010).
  • Choi WI , KimJY, KangC, ByeonCC, KimYH, TaeG. Tumor regression in vivo by photothermal therapy based on gold-nanorod-loaded, functional nanocarriers. ACS Nano5(3), 1995–2003 (2011).
  • Cardinal J , KluneJR, ChoryEet al. Noninvasive radiofrequency ablation of cancer targeted by gold nanoparticles. Surgery 144(2), 125–132 (2008).
  • Glazer ES , ZhuC, HamirAN, BorneA, ThompsonCS, CurleySA. Biodistribution and acute toxicity of naked gold nanoparticles in a rabbit hepatic tumor model. Nanotoxicology DOI: 10.3109/17435390.2010.516026 (2010).
  • Donaldson K , MurphyF, SchinwaldA, DuffinR, PolandCA. Identifying the pulmonary hazard of high aspect ratio nanoparticles to enable their safety-by-design. Nanomedicine6(1), 143–156 (2011).
  • Moran CH , WainerdiSM, CherukuriTKet al. Size-dependent joule heating of gold nanoparticles using capacitively coupled radiofrequency fields. Nano Res. 2(5), 400–405 (2009).
  • Curley SA , CherukuriP, BriggsKet al. Noninvasive radiofrequency field-induced hyperthermic cytotoxicity in human cancer cells using cetuximab-targeted gold nanoparticles. J. Exp. Ther. Oncol 7(4), 313–326 (2008).
  • Glazer ES , CurleySA. Radiofrequency field-induced thermal cytotoxicity in cancer cells treated with fluorescent nanoparticles. Cancer116(13), 3285–3293 (2010).
  • Gannon CJ , CherukuriP, YakobsonBIet al. Carbon nanotube-enhanced thermal destruction of cancer cells in a noninvasive radiofrequency field. Cancer 110(12), 2654–2665 (2007).
  • Li D , JungYS, TanS, KimHK, ChoryE, GellerDA. Negligible absorption of radiofrequency radiation by colloidal gold nanoparticles. J. Colloid. Interface Sci358(1), 47–53 (2011).
  • Nergiz SZ , SingamaneniS. Reversible tuning of plasmon coupling in gold nanoparticle chains using ultrathin responsive polymer film. ACS Appl. Mater. Interfaces3(4), 945–951 (2011).
  • Wardle EN . Kupffer cells and their function. Liver7(2), 63–75 (1987).
  • Glazer ES , ZhuC, MasseyKLet al. Noninvasive radiofrequency field destruction of pancreatic adenocarcinoma xenografts treated with targeted gold nanoparticles. Clin. Cancer Res. 16(23), 5712–5721 (2010).
  • Khan JA , KudgusRA, SzabolcsAet al. Designing nanoconjugates to effectively target pancreatic cancer cells in vitro and in vivo PLoS One 6(6), e20347 (2011).
  • Almeida JP , ChenAL, FosterA, DrezekR. In vivo biodistribution of nanoparticles. Nanomedicine6(5), 815–835 (2011).
  • Ali MM , YooB, PagelMD. Tracking the relative in vivo pharmacokinetics of nanoparticles with PARACEST MRI. Mol. Pharm6(5), 1409–1416 (2009).
  • Warsi MF , ChechikV. Strategies for increasing relaxivity of gold nanoparticle based MRI contrast agents. Phys. Chem. Chem. Phys13(20), 9812–9817 (2011).
  • Portney NG , OzkanM. Nano-oncology: drug delivery, imaging, and sensing. Anal. Bioanal. Chem384(3), 620–630 (2006).
  • Tiwari DK , JinT, BehariJ. Bio-distribution and toxicity assessment of intravenously injected anti-HER2 antibody conjugated CdSe/ZnS quantum dots in Wistar rats. Int. J. Nanomedicine6, 463–475 (2011).
  • Mo SM , OhIJ. Release of adriamycin from poly(lactide-co-glycolide)-polyethylene glycol nanoparticles. J. Nanosci. Nanotechnol.11(2), 1795–1798 (2011).
  • Butterworth KT , CoulterJA, JainSet al. Evaluation of cytotoxicity and radiation enhancement using 1.9 nm gold particles: potential application for cancer therapy. Nanotechnology 21(29), 295101 (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.